Skip to megamenu (after main content)
Meet us next:   BIO International Convention 2025 – 4 September  ●  ELRIG – Drug Discovery in Scotland 2025 – 17 September  ●  The Cell & Gene Meeting on the Mesa 2025 – 6-8 October (in person) & 9-10 October (virtual)  ●  ELRIG – Drug Discovery – 21-22 October  ●  more on our events calendar
Prices for NutriStem, NutriCoat, and NutriFreez products will increase effective 1st August. Lock in the current price by getting your order by 31st July.

Clinical Stem Cell Services

GMP‑Grade iMSC & MSC Manufacturing and MCB Generation

REPROCELL delivers GMP Master Cell Banks (MCBs) of mesenchymal stem cells (MSCs)—also known as Mesenchymal Stromal Cells and Medicinal Signaling Cells—manufacturing services for conventional MSCs and iPSC-derived MSCs (iMSCs), tailored to your next clinical project. Our production adheres to US FDA, European EMA, and Japanese PMDA standards to ensure consistent, therapeutic-grade quality. Off-the-shelf GMP iMSC and MSC banks are also available for immediate clinical use—streamlining your MSC therapy supply chain.

Why choose GMP-grade MSCs?

Derived from iPSCs, our GMP-grade iMSCs and research-grade iMSCs offer a scalable, consistent alternative to primary MSCs. They deliver higher batch‑to‑batch uniformity and potency, enabling for a large-scale, robust, cost-effective MCB production. 

Discover why iMSCs are capturing the spotlight—and how they stack up against traditional primary MSCs—on our blog:

Primary MSC Isolation and GMP‑Grade Expansion

Conventional primary MSCs can be isolated from multiple sources—such as bone marrow, adipose tissue, cord blood, or placenta—purified and robustly expanded under GMP‑grade conditions to yield therapeutic‑scale cell quantities. Alternatively, iMSCs provide a scalable, xeno‑free source of MSCs. Both primary MSCs and iMSCs support scalable expansion and directed differentiation into cartilage, muscle, bone, and other clinically relevant tissue types, positioning them as versatile platforms in GMP MSC production and cell therapy development.

Clinical-MSC-service-figure-1

Scalable GMP MSC/iMSC MCB Production and CDMO Partnerships

At our REPROCELL USA facility, we specialize in producing custom GMP-grade iMSCs and iMSC MCBs—either derived from our StemRNA Clinical iPSC clones or your company’s proprietary iPSC line.

Whether you are initiating a new preclinical study or preparing for late-stage development, our dedicated GMP manufacturing facility is equipped to produce clinically compliant iMSC MCBs at scale. With our European partner, we provide cGMP‑manufactured MSCs, MCBs, and Working Cell Banks (WCBs) covering custom and off-the-shelf services for clinical and research applications worldwide.

REPROCELL ’s GMP MSC and iMSC Services Ready-to-use GMP MSCs at Cellcolabs (Sweden) GMP iMSC MCB Manufacturing Service at REPROCELL USA GMP MSC MCB Manufacturing Service at Histocell (Europe)

GMP MCB Manufacturing Service at
REPROCELL USA

We now offer full-service GMP-grade MCB production for iPSCs and iMSCs at our cutting-edge Beltsville, MD facility:

  • A closed, modular Cytocentric Xvivo system
  • Class 100 (ISO 5) containment
  • Complete with HEPA‑filtered,
  • Monitored environments

This modular system drastically reduces contamination risk while accelerating turnaround times.

REPROCELL USA 5

Lab staff using the BioSpherix System

BioSpherix System 4


GMP MCB Manufacturing Service at
Histocell in Europe

We have partnered with Histocell, a Spain‑based CDMO with a fully authorized GMP‑ATMP facility in Bilbao for both clinical iPSC and MSC therapies:

  • 13+ years of GMP experience
  • Seven clean rooms
  • Automated fill/finish
  • Multiple QC labs
  • Ability to run autologous and allogeneic batches at both pilot and clinical scale

We support everything from custom MSCs and iPSC MCB manufacturing to secretome/exosome products.  

histocell-spain

Histocell-lab-1

Histocell-lab-2


Our MSC and iMSC related services: Isolation, Expansion & Differentiation

  • Isolation and expansion of autologous or allogeneic adult adipose-derived MSCs
  • Expansion of autologous and allogeneic adult bone marrow MSCs
  • Mesodermal Trilineage differentiation of MSCs (chondrocytes, osteocytes, myocytes)
  • Production and characterization of cell-derived products like secretome and exosomes

We provide all regulatory QC specified by the EMA or FDA, and all the required documentary support for the GMP product.


FAQs


Also Available


We Can Also Help with Your Research MSC Project

R&D lab – GMP-like production and QC

  • Fully equipped Molecular biology lab includes:
    • Cytofluorometry
    • Spectrophotometry
    • Immunohistochemistry
  • Suitable for general R&D projects
  • Provides a GMP-like tech-transfer phase
  • Uses Quality Control similar to cell therapy drugs

Histocell lab


Off-the-Shelf GMP MSCs and Exosomes from Cellcolabs
(Solna, Sweden)

Cellcolabs_CC-BM-hMSC

20+ Years of Karolinska Research Supports Cellcolabs MSC Production

Discover our GMP-grade MSCs—our "Ready-to-Use GMP MSCs" are produced in collaboration with Cellcolabs (Solna, Sweden), drawing on over 20 years of Karolinska Institute research and clinical trial experience. These young, extensively screened donor-derived bone marrow MSCs are expanded in xeno-free media, cryopreserved at passage 3, and thoroughly QC-tested for sterility, karyotype, viability, and surface marker expression, ensuring a reliable, off-the-shelf asset for regenerative and immunomodulatory therapy projects.


Ask our experts about our GMP MSC production service